Gemcitabine for Injection, USP, 2 g*/vial, Lyophilized powder in a Single-Use Vial, Rx only, Manufactured for: Mylan Institutional LLC, Rockford, IL 61103, Made in India, NDC 67457-463-02, UPC 3 67457 46302 5.
Class I - DangerousWhat Should You Do?
- Check if you have this product: Lot #: 7801221, 7801222, Exp 03/16
- Do not eat it: Even if it looks and smells fine, do not consume this product.
- Throw it away or return it: You can return the product to the store for a full refund.
- Seek medical attention if needed: If you've consumed this product and feel unwell, contact your doctor immediately.
- Report problems: Report any issues to the FDA's Safety Reporting Portal.
⚠️ Emergency: If you experience severe symptoms after consuming this product, call 911 or Poison Control at 1-800-222-1222.
Recall Details
- Company:
- Mylan Institutional LLC
- Reason for Recall:
- Presence of Particulate Matter
- Classification:
- Class I - Dangerous
Dangerous or defective products that predictably could cause serious health problems or death.
- Status:
- terminated
Product Information
Full Description:
Gemcitabine for Injection, USP, 2 g*/vial, Lyophilized powder in a Single-Use Vial, Rx only, Manufactured for: Mylan Institutional LLC, Rockford, IL 61103, Made in India, NDC 67457-463-02, UPC 3 67457 46302 5.
Product Codes/Lot Numbers:
Lot #: 7801221, 7801222, Exp 03/16
Official Source
Always verify recall information with the official FDA source:
View on FDA.govFDA Recall Number: D-1333-2015
Related Recalls
Class I - Dangerous
Super-Potent Drug: Out of specification potency results were obtained.
Class I - Dangerous
Super-Potent Drug: Out of specification potency results were obtained.
Class I - Dangerous
Subpotent and Superpotent Drug